Silvercrest Asset Management Group »

Rhythm Pharmaceuticals shares owned by Silvercrest Asset Management Group

Quarter-by-quarter ownership of Rhythm Pharmaceuticals (RYTM) shares owned by Silvercrest Asset Management Group from 13F filings

Historical chart of Silvercrest Asset Management Group investment in Rhythm Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rhythm Pharmaceuticals held by Silvercrest Asset Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rhythm Pharmaceuticals by Silvercrest Asset Management Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.4M 34k 100.99
2025-06-30 $3.1M 49k 63.19

More positions owned by Silvercrest Asset Management Group

Microsoft Corporation (MSFT)
Broadcom (AVGO)
Apple (AAPL)
Alphabet Inc Class C cs (GOOG)
Ishares Tr Rus 1000 Grw Etf (IWF)
Abbott Laboratories (ABT)
Oracle Corporation (ORCL)
Cadence Bank (CADE)
Glacier Ban (GBCI)
Home Depot (HD)
Vanguard Scottsdale Fds Vng Rus1000grw (VONG)
Williams Companies (WMB)
Cisco Systems (CSCO)
Atmos Energy Corporation (ATO)
Alphabet Inc Class A cs (GOOGL)

View all positions for Silvercrest Asset Management Group

Top funds holding Rhythm Pharmaceuticals

Perceptive Advisors
BlackRock
RA Capital Management
Baker Bros. Advisors
Vanguard Group
PRIMECAP Management Company
NEA Management Company
FMR
State Street Corporation
Goldman Sachs Group
Federated Investors
Driehaus Capital Management
Geode Capital Management
Polar Capital Holdings
Jpmorgan Chase & Co

View all funds holding Rhythm Pharmaceuticals